To determine which of the following is not a sexually transmitted disease (STD), we need to examine the options provided in the context of common knowledge about diseases and transmission methods:
From this analysis, it is clear that Filariasis is not transmitted sexually and therefore is not a sexually transmitted disease (STD).
(1) Chlamydiasis
Chlamydiasis is a sexually transmitted disease (STD) caused by the bacterium Chlamydia trachomatis. It can affect both men and women and is one of the most common STDs.
(2) Filariasis
Filariasis is a disease caused by parasitic worms called filarial worms. It is transmitted through mosquito bites and is not a sexually transmitted disease. Filariasis can lead to conditions such as elephantiasis.
(3) Genital herpes
Genital herpes is a sexually transmitted disease caused by the herpes simplex virus (HSV). It can cause painful sores and blisters on or around the genitals.
(4) Trichomoniasis
Trichomoniasis is a sexually transmitted disease caused by the protozoan parasite Trichomonas vaginalis. It can affect both men and women and often causes symptoms such as itching and discharge.
Conclusion
Based on the explanations above, the disease that is not sexually transmitted is:
Therefore, the correct answer is (2) Filariasis.
(1) They are considered safe during the first trimester.
This statement is correct. Medical Termination of Pregnancy (MTP) is generally considered safe when performed during the first trimester (up to 12 weeks of pregnancy).
(2) It is legalized in India from 1971.
This statement is correct. MTP was legalized in India with the Medical Termination of Pregnancy Act in 1971.
(3) MTP can be performed even after 24 weeks, but with the opinion of 2 registered medical practitioners on specific grounds.
This statement is correct. According to the Medical Termination of Pregnancy Act in India, MTP can be performed after 24 weeks with the opinion of two registered medical practitioners on specific grounds, such as severe fetal abnormalities or risks to the woman's life.
(4) About 20% of the total number of conceived pregnancies undergo MTP in a year globally.
This statement is incorrect. The global rate of MTP varies significantly by region and country, and it is not accurate to state that about 20% of all pregnancies globally undergo MTP. The actual rates are influenced by various factors, including access to healthcare, cultural attitudes, and legal restrictions.
Conclusion
The incorrect statement is (4) About 20% of the total number of conceived pregnancies undergo MTP in a year globally.
List-I Various Assisted Reproductive Technologies | List-II Process Involved |
---|---|
(A) ZIFT | (III) Transferring of fertilised egg up to 8 blastomeres into fallopian tube |
(B) ICSI | (I) Formation of embryo in vitro by injecting sperm directly into ovum |
(C) IUI | (IV) Transfer of semen from a healthy donor into the uterus artificially |
(D) IUT | (II) Transferring of embryo with more than 8 blastomeres into the uterus |
In order to correctly match List-I with List-II, we must understand the various Assisted Reproductive Technologies (ART) mentioned in the question:
By matching these processes with the corresponding assisted reproductive technologies, we derive the following answers:
List-I | List-II |
---|---|
(A) ZIFT | (III) |
(B) ICSI | (I) |
(C) IUI | (IV) |
(D) IUT | (II) |
Therefore, the correct answer is: (A) - (III), (B) - (I), (C) - (IV), (D) - (II)
To solve the problem of matching List-I with List-II for various Assisted Reproductive Technologies (ART), we need to understand the definitions and processes involved in each technology listed:
Therefore, the correct option is: (A) - (III), (B) - (I), (C) - (IV), (D) - (II).
The question asks which method of contraception is not meant for females. Let's analyze the options:
Based on the above analysis, the method of contraception not meant for females is Vasectomy.
(1) IUDs
Intrauterine devices (IUDs) are a form of contraception that is specifically meant for females. They are inserted into the uterus to prevent pregnancy.
(2) Lactational amenorrhea
Lactational amenorrhea is a natural form of contraception that occurs in females. It refers to the temporary cessation of menstruation due to breastfeeding, which can prevent ovulation and pregnancy.
(3) Vasectomy
Vasectomy is a surgical procedure that involves cutting or sealing the vas deferens in males to prevent sperm from entering the ejaculate. This method of contraception is specifically meant for males.
(4) Condoms
Condoms are a barrier method of contraception that can be used by both males and females. They prevent pregnancy by blocking the transfer of sperm during sexual intercourse.
Conclusion
The method of contraception that is not meant for females is (3) Vasectomy.
The oral contraceptive pill ‘Saheli’, known as the ‘Once a week’ pill, was developed by the Central Drug Research Institute (CDRI). CDRI is an eminent research institute in India known for its contributions to pharmaceuticals and drug development.
India, being a pioneer in addressing reproductive health, started national programmes in 1951. These programmes evolved into broader initiatives, including family planning strategies to promote reproductive health.
Understanding the agencies involved in such developments is essential for recognizing the entities contributing to national health goals.
Therefore, the correct option is CDRI.
(1) AIIMS
AIIMS (All India Institute of Medical Sciences) is a renowned medical institution in India, but it was not involved in the development of the Saheli oral contraceptive pill.
(2) NBRI
NBRI (National Botanical Research Institute) is a scientific research institution in India, but it was not involved in the development of the Saheli oral contraceptive pill.
(3) CDRI
CDRI (Central Drug Research Institute) in Lucknow, India, is the correct answer. Dr. Nitya Anand, who was associated with CDRI, developed the Saheli oral contraceptive pill[^9^][^10^][^18^][^19^][^20^][^23^]. Saheli, also known as Centchroman, is the world's first non-steroidal, non-hormonal oral contraceptive pill[^18^].
(4) NBPGR
NBPGR (National Bureau of Plant Genetic Resources) is an organization focused on plant genetic resources and was not involved in the development of the Saheli oral contraceptive pill.
Conclusion
The correct answer is (3) CDRI, as Saheli was developed by Dr. Nitya Anand at the Central Drug Research Institute[^9^][^10^][^18^][^19^][^20^][^23^].